Join us! Live Webcast December 12 -- How the FDA Impacts the Parkinson's Community

Sign up now for PAN's Webcast and hear from experts about how the Food & Drug Administration's work Impacts the Parkinson's Community.

Join the Parkinson's Action Network and viewers across the country for a live, educational webcast and learn why the Food and Drug Administration is important to the Parkinson's community!  This educational webcast provides a unique opportunity to gain valuable insights into the FDA, the role it plays in therapy development, and possible areas for needed change and improvement.

When:  Monday, December 12
           3 – 4:30 p.m.

Where: Click here to register online to view the webcast.

Moderator:
Amy Comstock Rick, JD
CEO, Parkinson's Action Network

Panelists:
Marc Walton, MD, PhD
Associate Director for Translational Medicine in the Office of Translational Sciences at the Center for Drug Evaluation and Research, FDA

Michelle McMurry-Heath, MD, PhD
Associate Director for Science at the Center for Devices and Radiological Health, FDA

Cartier Esham, PhD
Senior Director of Emerging Companies Health and Regulatory Affairs for the Biotechnology Industry Organization (BIO)

Jackie Christensen
Patient-Representative to the Food and Drug Administration's Office of Special Health Issues

This program is made possible by a conference support grant awarded from and administered by the Telemedicine & Advanced Technology Research Center (TATRC) of the U.S. Army Medical Research & Materiel Command (USAMRMC), Award # W23RYX1067N603

With additional contributions from: